IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.698
EU - Europa 4.983
AS - Asia 1.840
OC - Oceania 12
AF - Africa 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 13.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.670
PL - Polonia 2.511
CN - Cina 790
UA - Ucraina 641
DE - Germania 503
IT - Italia 500
SG - Singapore 420
HK - Hong Kong 241
FI - Finlandia 208
GB - Regno Unito 156
RU - Federazione Russa 153
TR - Turchia 132
IE - Irlanda 130
VN - Vietnam 93
IN - India 56
FR - Francia 47
ID - Indonesia 47
BE - Belgio 32
CZ - Repubblica Ceca 30
SE - Svezia 25
CA - Canada 23
AU - Australia 11
ES - Italia 10
IR - Iran 10
NL - Olanda 10
EU - Europa 9
KR - Corea 9
CH - Svizzera 7
JP - Giappone 7
PH - Filippine 6
TW - Taiwan 5
LK - Sri Lanka 4
LT - Lituania 4
MA - Marocco 4
AR - Argentina 3
AZ - Azerbaigian 3
BD - Bangladesh 3
MU - Mauritius 3
PE - Perù 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
MX - Messico 2
NO - Norvegia 2
PA - Panama 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 13.563
Salva come PNG Salva come JPEG
Città #
Warsaw 2.508
Fairfield 1.066
Woodbridge 670
Ashburn 604
Jacksonville 495
Houston 476
Cambridge 412
Seattle 396
Singapore 361
Ann Arbor 348
Chandler 347
Wilmington 333
Brescia 269
Princeton 237
Hong Kong 236
Nanjing 152
Beijing 143
Helsinki 133
New York 127
Dublin 124
Dearborn 123
Istanbul 118
Dong Ket 90
Shanghai 60
Des Moines 59
Munich 59
Moscow 58
Nanchang 48
Jakarta 46
Shenyang 46
Hebei 40
Milan 40
San Diego 39
Los Angeles 37
Changsha 36
Jinan 36
Brussels 30
Lancaster 28
Brno 27
Tianjin 27
London 22
San Francisco 22
Boardman 20
Phoenix 20
Kunming 19
Taizhou 16
Hangzhou 15
San Mateo 14
Washington 14
Jiaxing 13
Lappeenranta 13
Ningbo 13
Falkenstein 12
Haikou 12
Rome 11
Romola 11
Hefei 10
Nürnberg 10
Ottawa 10
Toronto 10
Zhengzhou 10
Frankfurt am Main 9
Kocaeli 9
Guangzhou 8
Lanzhou 8
Santa Clara 8
Verona 8
Ardabil 7
Kilburn 7
Norwalk 7
Redwood City 7
Augusta 6
Boston 6
Chicago 6
Fuzhou 6
Orange 6
Turin 6
Acton 5
Florence 5
Gunzenhausen 5
Salerno 5
Taipei 5
Taiyuan 5
Zurich 5
Calvisano 4
Colombo 4
Irpin 4
Leawood 4
Lonate Ceppino 4
Palermo 4
Pavia 4
Pune 4
Tokyo 4
Urbino 4
Wuhan 4
Angeles City 3
Baku 3
Baliuag 3
Barcelona 3
Canberra 3
Totale 10.989
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 288
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 251
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 242
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 233
Tumor angiogenesis revisited: Regulators and clinical implications 232
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 230
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 230
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 229
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 226
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 226
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 221
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 221
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 218
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 214
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 207
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 205
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 202
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 200
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 195
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 191
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 190
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 166
Long pentraxin-3 follows and modulates bladder cancer progression 163
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 159
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 158
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 156
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 155
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 147
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 144
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 141
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 138
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 135
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 134
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 134
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 132
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 128
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 127
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 126
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 125
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 125
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 124
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 123
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 122
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 122
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 120
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 117
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 115
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 114
Beta-Galactosylceramidase deficiency: neurovascular implications 114
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 114
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 113
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 111
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 111
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 111
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 108
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 108
Heparin derivatives as angiogenesis inhibitors 106
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 106
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 106
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 105
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 105
Long pentraxin 3: A novel multifaceted player in cancer 105
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 103
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 102
Future applications of FGF/FGFR inhibitors in cancer 97
Vascular disrupting activity of combretastatin analogues 95
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 94
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 93
Circulating microRNAs and Their Role in Multiple Myeloma 92
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 87
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 87
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 86
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 86
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 85
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 84
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 83
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 82
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 80
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 78
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 74
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 73
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 70
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 70
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 68
TR-764 is a novel tubulin binding agent with strong antiangiogenic activity. 68
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 66
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 63
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 63
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 62
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 62
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 60
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 60
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 59
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 57
Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes 56
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 55
Suppressive and activating antigen presenting cells originate from a common myeloid precursor 54
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents 54
The FGF/FGFR System in the Physiopathology of the Prostate Gland 54
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 54
Totale 12.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.504 0 0 0 0 0 475 421 428 334 435 201 210
2020/20212.366 94 235 95 274 143 227 151 253 255 247 238 154
2021/20221.124 88 199 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20251.060 34 40 43 445 240 258 0 0 0 0 0 0
Totale 13.904